In the production of human vaccines, Sunresin’s multimodal chromatography resins are usually combined with ion exchange chromatography such as Seplife Q Large Scale, or combined with gel filtration chromatography Seplife 4FF to complete the entire purification process.

The Core-Shell multi-mode chromatography medium is a new multi-mode agarose chromatography medium independently developed by Sunresin Technology, used for purification and polishing of biological macromolecules such as viruses.

The list of "The 16th Listed Company Value Selection" of China was announced. Sunresin New Materials Co., Ltd. was selected into the "Top 50 Most Valuable Listed Companies on the Growth Enterprise Market" list. "China’s Listed Company Value Selection" is hosted by Securities Times and has been held for 16 consecutive years, as one of the most influential selections in the field of listed companies hosted by mainstream financial media in China.

On September 21, Jintai Lithium Industry’s Phase-Two 4000t/a lithium carbonate project undertaken by Sunresin started production. Up to now, Sunresin has completed an accumulated 7000t/a lithium carbonate for Jintai Lithium Industry.

Sunresin is delighted to announce that a Memorandum of Understanding ("MoU") has been signed with Anson Resources Limited (ASX: ASN), an Australian-based exploration and development company for industrial minerals, on a long-term alliance for the Paradox lithium project in Utah.

Sunresin is pleased to enter into a Memorandum of Understanding ("MoU") with CleanTech Lithium PLC (AIM: CTL), a lithium exploration and development company in Chile, for the development of lithium extraction projects.

The Phase One adsorption equipment for the 25,000 ton per annum Angeles salt lake Lithium Extraction project in Argentina have been shipped from the System Engineering Park of Sunresin, in Gaoling, Shaanxi Province of China. The contract of this Lithium Extraction Project from salt lakes in Argentina was signed in March 2022. According to the contract, the production and delivery of the adsorbents and equipment will be completed by the end of 2022.

Vaccines matter, and the purification process matters for vaccine manufacturing. The 2nd China International Vaccine Innovation Summit (HVIS) took place in Beijing, From 8-9 August.